New Indications and Dosage Forms for 2013
See also: New Drug Approvals for 2013
January 8, 2013
January 18, 2013
January 23, 2013
January 25, 2013
- Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease
- FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia
February 25, 2013
- Epiduo Gel Becomes First Topical Prescription Acne Treatment Available For Children As Young As 9 Years Old
- FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
March 26, 2013
April 15, 2013
April 23, 2013
April 30, 2013
- FDA Approves Actemra for Children with Polyarticular Juvenile Idiopathic Arthritis
- FDA Approves Plan B One-Step Emergency Contraceptive Without a Prescription for Women 15 Years of Age and Older
May 3, 2013
May 10, 2013
May 15, 2013
- FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer
- FDA Approves Simponi to Treat Ulcerative Colitis
June 5, 2013
June 11, 2013
June 13, 2013
June 20, 2013
June 21, 2013
- FDA Approves U.S. Product Labeling Update for Sprycel (dasatinib) to Include Three-Year First-Line and Five-Year Second-Line Efficacy and Safety Data in Chronic Myeloid Leukemia in Chronic Phase
- FDA Approves Vibativ for Hospitalized Patients with Bacterial Pneumonia
June 24, 2013
June 28, 2013
July 1, 2013
July 2, 2013
August 2, 2013
September 6, 2013
September 11, 2013
September 23, 2013
September 24, 2013
September 30, 2013
- FDA Approves Cimzia for Treatment of Adult Patients with Active Psoriatic Arthritis
- FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment
October 11, 2013
October 18, 2013
October 22, 2013
October 28, 2013
November 22, 2013
- FDA Approves Nexavar to Treat Metastatic Differentiated Thyroid Cancer
- FDA Approves First Adjuvanted Vaccine for Prevention of H5N1 Avian Influenza